AMY LECUONA: Open Payments
NPI 1457855603 · LECANTO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,260 in 36 payments from 13 companies in 2025. Trend: 2023 $1,632 · 2024 $1,474 · 2025 $1,260
Food & beverage: $1,260
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $254 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $212 |
| LEO Pharma Inc. | 5 | $209 |
| UCB, Inc. | 3 | $139 |
| Janssen Biotech, Inc. | 1 | $125 |
| Lilly USA, LLC | 3 | $75 |
| PFIZER INC. | 4 | $65 |
| Amgen Inc. | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| GENZYME CORPORATION | 1 | $36 |
Products named: ILUMYA, SKYRIZI, ANZUPGO, Bimzelx, TREMFYA, CIBINQO, DUPIXENT, TALTZ.
Industry payments across FL — which companies pay providers there.
